About MIG Capital
MIG Capital is a venture capital firm founded in 2004. It is primarily based out of Munich, Germany. As of Jul 2026, MIG Capital is an active investor, having invested in 52 companies, with 3 new investments in the last 12 months. It primarily invests in Series A round in Germany based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Series A round of Luffy AI Overall, MIG Capital portfolio has seen 1 unicorn, 2 IPOs and 10 acquisitions including key companies like IQM, BioNTech and NFON. A lot of funds co-invest with MIG Capital, with names like Kfw sharing a substantial percentage of its portfolio. MIG Capital has team of 16 people including 11 partners.Key Metrics
Team Members
Portfolio Sectors
Rounds of Entry
Series A, Series B & 4 more
Portfolio Acquisitions
Portfolio Unicorns
Deals in last 12 months
MIG Capital's List of Top Investments
MIG Capital has a portfolio of 52 companies, one of which is a Unicorn. Their most notable investments are in KONUX and HawkCell.Their portfolio spans across Germany, France, Austria and 5 more locations. They have invested in Life Sciences, High Tech, Enterprise Applications and 18 other sectors, across stages such as Series A, Series B and 4 more. Here is the list of top investments by MIG Capital:1. IQM
Developer of superconducting quantum computers. Its features include quantum processors with on-chip components that increase QPU clock speed for error correction, as well as application-specific processors and quantum operations.
Key facts about IQM
- Founded Year: 2018
- Location: Espoo (Finland)
- Annual Revenue: €10M - €50M as on Dec 31, 2025
- Valuation: $*****
- Stage: Series B
- Total Funding till date: $600M
- Employee Count: 399 as on May 31, 2026
- Investors: Ten Eleven Ventures, Samsara BioCapital and 27 Others
- Latest Funding Round: Conventional Debt, Mar 30, 2026, $*****
- Highlight: Editors' Pick
2. BioNTech
Developer of immunotherapeutics for the treatment of cancer and other diseases. Its oncology drug pipeline contains several classes of drugs which include mRNA treatments, modified cell therapies, antibodies, and small molecule immunomodulators that have been optimised for distinct modes of action, high precision targeting, potency, and efficacy.
Key facts about BioNTech
- Founded Year: 2008
- Location: Mainz (Germany)
- Stage: Public
- Total Funding till date: $861M
- Employee Count: 5,188 as on Aug 31, 2026
- Investors: Fidelity Investments, Janus Henderson Investors and 28 Others
- Latest Funding Round: Post IPO, Apr 14, 2022, $*****
- Highlight: Public
3. AMSilk
Manufacturer of biotech silk protein materials for various industry applications. The company utilizes protein design and precision fermentation to produce materials with superior performance and lower environmental impact. These materials are available in formulations including fibers, yarns, hydrogels, and silk powder. The company provides these materials to enhance consumer lives across multiple industries.
Key facts about AMSilk
- Founded Year: 2008
- Location: Neuried (Germany)
- Annual Revenue: €0 - €1M as on Dec 31, 2024
- Stage: Series D
- Total Funding till date: $130M
- Employee Count: 78 as on Aug 31, 2026
- Investors: Cargill, Novo Holdings and 9 Others
- Latest Funding Round: Series D, Sep 09, 2025, $*****
- Highlight: Editors' Pick
4. Mimi
Provider of personalized audio solutions and hearing tests. It offers sound personalization technology adaptable to individual hearing profiles, enhancing audio experiences across headphones, televisions, and speakers. It also provides a hearing test app, generating a hearing profile used to create customized audio presets. It aims to restore missing audio details, enhance clarity, and eliminate the need for high volume settings. The resulting data contributes to a database of hearing profiles, informing research on hearing trends.
Key facts about Mimi
- Founded Year: 2014
- Location: Berlin (Germany)
- Stage: Series B
- Total Funding till date: $25.4M
- Employee Count: 43 as on Aug 31, 2026
- Investors: Atlantic Labs, MIG Fonds and 16 Others
- Latest Funding Round: Series B, Dec 15, 2021, $*****
- Highlight: Editors' Pick
5. Innatera
Provider of neuromorphic microprocessors. It leverages a computing system called spiking neural network to encode voltage spikes, realize its cognitive functions, and to encode sensor information through which the processor can mimic the brains mechanisms.
Key facts about Innatera
- Founded Year: 2018
- Location: Rijswijk (Netherlands)
- Stage: Series A
- Total Funding till date: $43.3M
- Employee Count: 124 as on Aug 31, 2026
- Investors: b2venture, Matterwave Ventures and 6 Others
- Latest Funding Round: Series A, Jun 27, 2024, $*****
- Highlight: Editors' Pick
MIG Capital's Year-on-Year Investment Trends
MIG Capital has invested in 52 companies over the last 20 years, with an average of 2 new investments annually in the last 10 years. In 2025, it made 4 investments, while as of Jul 2026, it has made 3 investments in this year. Its most recent first time investment was in Luffy AI and most recent follow-on round was in GlassPoint.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 2 | 1 | 3 |
2025 | 2 | 2 | 4 |
2024 | 3 | 3 | 6 |
2023 | 2 | 2 | 4 |
2022 | 3 | 2 | 5 |
2021 | 3 | 2 | 5 |
2020 | 3 | 4 | 7 |
2019 | 2 | 1 | 3 |
2018 | 4 | 1 | 5 |
2017 | 0 | 2 | 2 |
MIG Capital's Investments by Stage
MIG Capital has made 17 investments in Series A stage with an average round size of $10.3M, 8 investments in Series B stage with an average round size of $27.5M and 7 investments in Seed stage with an average round size of $8.26M.Stage of entry | No. of Investments |
|---|---|
Series A | 17 |
Series B | 8 |
Seed | 7 |
Series C | 4 |
Series D | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
MIG Capital's Investments by Sector
MIG Capital has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Enterprise Applications, HealthTech and Semiconductors. Notably, it has invested in 46 Tech companies, 45 Enterprise (B2B) companies, 20 Software companies and at least 17 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 18 |
High Tech | 13 |
Enterprise Applications | 8 |
HealthTech | 5 |
Semiconductors | 5 |
Others | 21 |
Note: We have considered here, only first round of investments
MIG Capital's Investments by Geography
MIG Capital has made most investments in Germany (26), followed by France where it has made 4 investments.Country | No. of Investments |
|---|---|
Germany | 26 |
France | 4 |
Austria | 2 |
Netherlands | 2 |
United Kingdom | 2 |
Others | 3 |
Note: We have considered here, only first round of investments
MIG Capital's recent investments
MIG Capital has made 3 investments in 2026 so far. Luffy AI and TIBEAY Biosciences are the latest among them.Here are the most recent investments by MIG Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jul 07, 2026 | United Kingdom | Series A | 8644 | [+4] | |
Apr 15, 2026 | Netherlands | Series C | 2419 | [+2] | |
Jan 26, 2026 | United States | Series C | 7124 | ||
Nov 20, 2025 | France | Seed | 9954 | [+5] | |
Sep 09, 2025 | Germany | Series D | 1859 | [+1] |
Unicorns in MIG Capital's Portfolio
MIG Capital has 1 unicorn in its portfolio - IQM. The most recent unicorn in their portfolio is IQM which became a unicorn in 2025, 6 years after MIG Capital first invested in it.Here is a list of unicorns in MIG Capital's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
76 | Developer of superconducting quantum computers | 2018 | Espoo | Series B | tuhkknd |
IPOs and Publicly Listed companies in MIG Capital's Portfolio
2 of MIG Capital's portfolio companies have become public. BioNTech got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), Frankfurt Stock Exchange (FRA), in Oct 2019 at marketcap of undefined and NFON got listed on the Frankfurt Stock Exchange (FRA) at marketcap of $197M.Here are MIG Capital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 11, 2019 | - | - | 6502 | |
May 31, 2018 | - | - | 2407 |
Acquired companies in MIG Capital's Portfolio
10 companies from MIG Capital's portfolio have been acquired. The most recent acquisition was Wealthpilot in Dec 2025 by Finaplus for $*****.Here are MIG Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 04, 2025 | - | - | 1313 | |
Jun 28, 2022 | - | - | 9177 | |
Oct 04, 2021 | Feb 10, 2016 | Series A | 9263 | |
Mar 19, 2019 | May 08, 2006 | Series B | 2754 | |
Nov 12, 2018 | - | - | 5422 |
Team profile of MIG Capital
MIG Capital has a team of 16 members including 11 Partners and 3 Principals located in Germany, Singapore and 1 more location. MIG Capital's team does not sit on the board of any company as of now.Here is a list of top team members in MIG Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Munich | - | ||
Partner | Munich | - | ||
Partner | Munich | - | ||
Partner | Munich | - | ||
Partner | Munich | - | - | |
Partner | Munich | - | - | |
Partner | Munich | - | ||
Partner | Singapore | - | - | |
Partner | Johannesburg | - | - |
Co-investors of MIG Capital
Over the past 20 years, 199 investors have co-invested in MIG Capital's portfolio companies. This includes funds and angels.
- Invested before MIG Capital: MIG Fonds, HTGF and 50 others have invested in rounds before MIG Capital. There are 4 companies where MIG Fonds has invested before MIG Capital and 3 companies where HTGF has invested before MIG Capital.
- Top Co-investors of MIG Capital: 72 investors entered a company along with MIG Capital. These include investors like Kfw (5 companies).
- Invested after MIG Capital: A total of 75 investors have invested in MIG Capital's portfolio after their investments. Top Investors include EIC Fund (3 companies), Europa (3 companies) and European Innovation Council (2 companies).
Recent News related to MIG Capital
•
MIG Capital Invests £1.5M in Luffy AI's Series A Funding RoundPresse Portal•Jul 08, 2026•Luffy AI, MIG Capital, BGF
•
TRIMTECH Therapeutics Raises Additional $14 Million in Seed RoundStartup Rise EU•Jun 23, 2026•Johnson & Johnson Innovation, Trimtech Therapeutics, BGF, Johnson & Johnson and 2 others
•
mbiomics secures further EUR 12 million in Series A funding, totaling EUR 30 millionVenture Capital magazine•Apr 28, 2026•mbiomics, MIG Capital, Bayern Kapital
•
MIG Capital Invests in TIBEAY Biosciences, Securing EUR 35 MillionVenture Capital magazine•Apr 16, 2026•MIG Capital, TIBEAY Biosciences
•
MIG Capital Invests €32 Million in Deep Tech and Life Science CompaniesWebDisclosure•Mar 24, 2026•MIG Capital
•
Devoted Health Grows to Improve the Health and Well-Being of More AmericansDevoted Health•Jan 30, 2026•Devoted Health, The Private Shares Fund, NextView Ventures, Emerson Collective and 13 others
•
GlassPoint Secures $20M Funding for Solar Industrial Process Heat ExpansionMiningstockeducation•Jan 26, 2026•Maaden, Dun & Bradstreet, MIG Capital, GlassPoint and 2 others
•
NcodiN Secures €16M Seed Round to Break AI’s Main Bottleneck with the World’s Smallest LaserBusiness Wire•Nov 20, 2025•NcodiN, PhotonVentures, Verve Ventures, MIG Capital and 6 others
•
AMSilk Secures EUR 52M Strategic Financing to Accelerate Commercial GrowthPR Newswire•Sep 09, 2025•Evonik, Ajinomoto, MIG Capital, AMSilk and 4 others
•
Swiss BioTech ASTRA Therapeutics Secures €8.3M Seed Round for Precision ParasiticidesEU-Startups•Jul 24, 2025•Astra, MIG Capital, Digitalis Ventures, Borealis Ventures and 2 others
